Bumetanide Injection — FDA Drug Shortage

Resolved — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Bumetanide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Resolved. The shortage was first posted on Jan 31, 2018.

Shortage details

Status
Resolved
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6007-10
Dosage Form
Injection
Presentation
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10)
Initial Posting
Jan 31, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.